New Biosynthetic Psilocybin Hits The Psychedelics Market, Available For Research And Clinical Trials
September 2, 1:26 PM
With psilocybin among the favorites within psychedelics,
Indaptus Therapeutics Files For Mixed-Securities Shelf Offering Of Up To $200M
September 1, 6:00 PM
-Reuters
Activision Blizzard Files For Mixed-Securities Shelf Offering, Size Not Disclosed
September 1, 4:39 PM
-Reuters
Avadel Pharmaceuticals Files For Mixed-Securities Shelf Offering Of Up To $500M
August 31, 4:54 PM
-Reuters
Markforged Files For Stock Shelf Of Up To 4.1M Shares Of Common Stock By Selling Stockholder
August 31, 4:45 PM
-Reuters